CN105614874A - 一种改善疲劳状态的组合物 - Google Patents
一种改善疲劳状态的组合物 Download PDFInfo
- Publication number
- CN105614874A CN105614874A CN201610137141.7A CN201610137141A CN105614874A CN 105614874 A CN105614874 A CN 105614874A CN 201610137141 A CN201610137141 A CN 201610137141A CN 105614874 A CN105614874 A CN 105614874A
- Authority
- CN
- China
- Prior art keywords
- composition
- ribose
- extract
- prepared
- radix ginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims abstract description 101
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 43
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000000284 extract Substances 0.000 claims abstract description 34
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 30
- 235000020710 ginseng extract Nutrition 0.000 claims description 28
- 239000002994 raw material Substances 0.000 claims description 18
- 235000013305 food Nutrition 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 3
- 208000001640 Fibromyalgia Diseases 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 208000008445 altitude sickness Diseases 0.000 claims 1
- 208000031225 myocardial ischemia Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 206010016256 fatigue Diseases 0.000 abstract description 10
- 230000002929 anti-fatigue Effects 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 3
- 240000000759 Lepidium meyenii Species 0.000 abstract description 2
- 235000000421 Lepidium meyenii Nutrition 0.000 abstract description 2
- 235000012902 lepidium meyenii Nutrition 0.000 abstract description 2
- 230000001575 pathological effect Effects 0.000 abstract description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 15
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 10
- 230000009182 swimming Effects 0.000 description 9
- 230000036541 health Effects 0.000 description 8
- 241000411851 herbal medicine Species 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 102100026189 Beta-galactosidase Human genes 0.000 description 4
- 108010059881 Lactase Proteins 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 4
- 229950006790 adenosine phosphate Drugs 0.000 description 4
- 108010005774 beta-Galactosidase Proteins 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 229940116108 lactase Drugs 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229920002527 Glycogen Polymers 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000004279 orbit Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- 208000002705 Glucose Intolerance Diseases 0.000 description 2
- 244000131316 Panax pseudoginseng Species 0.000 description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000003205 diastolic effect Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 201000009104 prediabetes syndrome Diseases 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001320 aldopentoses Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002213 purine nucleotide Substances 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000014268 sports nutrition Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610137141.7A CN105614874B (zh) | 2016-03-11 | 2016-03-11 | 一种改善疲劳状态的组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610137141.7A CN105614874B (zh) | 2016-03-11 | 2016-03-11 | 一种改善疲劳状态的组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105614874A true CN105614874A (zh) | 2016-06-01 |
CN105614874B CN105614874B (zh) | 2019-04-05 |
Family
ID=56030571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610137141.7A Active CN105614874B (zh) | 2016-03-11 | 2016-03-11 | 一种改善疲劳状态的组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105614874B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1319344A (zh) * | 2001-03-30 | 2001-10-31 | 石家庄制药集团制药技术开发有限公司 | 一种运动保健食品 |
US20080233245A1 (en) * | 2007-03-19 | 2008-09-25 | Lesley Joan White | Liquid nutrient composition for improving performance |
CN104042662A (zh) * | 2014-06-20 | 2014-09-17 | 苏州法莫生物技术有限公司 | 一种复方玛咖粉制剂 |
CN104687044A (zh) * | 2015-02-03 | 2015-06-10 | 广东长兴生物科技股份有限公司 | 一种缓解男性性功能障碍、抗疲劳的功能性食品 |
CN104738638A (zh) * | 2015-01-09 | 2015-07-01 | 李晨悦 | 具有抗疲劳作用的组合物及其用途 |
CN104783185A (zh) * | 2015-03-31 | 2015-07-22 | 中华全国供销合作总社杭州茶叶研究所 | 一种具有增强免疫力、缓解体力疲劳功能的保健食品及其制备方法 |
-
2016
- 2016-03-11 CN CN201610137141.7A patent/CN105614874B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1319344A (zh) * | 2001-03-30 | 2001-10-31 | 石家庄制药集团制药技术开发有限公司 | 一种运动保健食品 |
US20080233245A1 (en) * | 2007-03-19 | 2008-09-25 | Lesley Joan White | Liquid nutrient composition for improving performance |
CN104042662A (zh) * | 2014-06-20 | 2014-09-17 | 苏州法莫生物技术有限公司 | 一种复方玛咖粉制剂 |
CN104738638A (zh) * | 2015-01-09 | 2015-07-01 | 李晨悦 | 具有抗疲劳作用的组合物及其用途 |
CN104687044A (zh) * | 2015-02-03 | 2015-06-10 | 广东长兴生物科技股份有限公司 | 一种缓解男性性功能障碍、抗疲劳的功能性食品 |
CN104783185A (zh) * | 2015-03-31 | 2015-07-22 | 中华全国供销合作总社杭州茶叶研究所 | 一种具有增强免疫力、缓解体力疲劳功能的保健食品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105614874B (zh) | 2019-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103271346B (zh) | 一种缓解体力疲劳保健食品 | |
CN111035649B (zh) | 一种nmn+glp复配营养补充剂及其制备方法和应用 | |
CN102160664A (zh) | 儿童营养饮料 | |
CN101961345B (zh) | 一种具有抗疲劳作用的药物组合物 | |
CN102669348A (zh) | 一种养益心脏的营养食品养心茶冲剂 | |
CN103704711B (zh) | 一种具有抗疲劳保健功能冲剂 | |
CN107343658A (zh) | 一种抗疲劳sod牡蛎肽复合胶囊及其制备方法 | |
CN100475254C (zh) | 用于提高人体免疫力及抗疲劳的抵抗力胶囊及其制备方法 | |
CN103463625B (zh) | 养心补血营养制剂 | |
CN101721403A (zh) | 岩藻黄素在减肥方面的应用 | |
CN102784230B (zh) | 一种治疗营养性贫血的药物组合物制剂 | |
CN105614874B (zh) | 一种改善疲劳状态的组合物 | |
WO2017121333A1 (zh) | 管花肉苁蓉萃取物及异类叶升麻苷于保护肌肉的用途 | |
CN101669984A (zh) | 抗疲劳免疫调节的中药制成品 | |
CN107308317A (zh) | 一种防治辐射损伤的中药组合物及辐射损伤动物模型的构建方法 | |
CN103083429A (zh) | 降血脂中药组方 | |
CN103719661B (zh) | 补血口服液保健品 | |
CN102631503A (zh) | 一种抗疲劳中药组合物及其制备方法 | |
CN101653445A (zh) | 酪醇半乳糖苷在制备耐缺氧及抗疲劳药物中的应用 | |
CN101991829B (zh) | 一种治疗胃病的药物 | |
CN105168887A (zh) | 益肾养元软胶囊及制备工艺 | |
CN101254199A (zh) | 人参皂苷Rg1与咖啡因组合物及其应用 | |
CN109758559A (zh) | 一种治疗慢性疲劳综合征的中药组合物及其制备方法和应用 | |
CN104256618A (zh) | 一种降血糖的食品、保健品或药物组合物 | |
CN103933150B (zh) | 一种具有改变睡眠质量功效的保健口服液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Zhengping Inventor after: Han Jun Inventor after: Yuan Baohui Inventor after: Liu Guiqin Inventor after: Li Dacheng Inventor after: Liu Min Inventor after: Zhou Hao Inventor before: Yuan Baohui Inventor before: Wang Zhengping Inventor before: Liu Guiqin Inventor before: Han Jun Inventor before: Li Dacheng Inventor before: Liu Min Inventor before: Zhou Hao |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170503 Address after: 226133 A5 building, Haimen biological medicine science and Technology Pioneer Park, Jiangsu, Nantong Applicant after: HAIMEN PINSHANG MEDICINE SCIENCE & TECHNOLOGY Co.,Ltd. Address before: 252059 Hunan Road, Dongchangfu, Shandong, No. 1, Applicant before: Liaocheng University |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: Building A5, Haimen Biomedical Technology Entrepreneurship Park, Nantong City, Jiangsu Province, 226133 Patentee after: Nantong Haimen Pinshang Pharmaceutical Technology Co.,Ltd. Address before: Building A5, Haimen Biomedical Technology Entrepreneurship Park, Nantong City, Jiangsu Province, 226133 Patentee before: HAIMEN PINSHANG MEDICINE SCIENCE & TECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |